EFFICACY AND SAFETY OF BEMPEDOIC ACID plus EZETIMIBE FIXED-DOSE COMBINATION IN PATIENTS AT HIGH CVD RISK AND WITH ELEVATED LDL-C RECEIVING MAXIMALLY TOLERATED STATIN THERAPY

著录项

• 来源
  《Atherosclerosis》 |2019年第2019期|共2页
• 作者

  Ballantyne C.; Laufs U.; Ray K. K.; Leiter L. A.; Bays H. E.; Goldberg A. C.; Stroes E. S. G.; MacDougall D.; Zhao X.; Catapano A. L.;

  展开▼
• 作者单位

  Baylor Coll Med Dept Med Houston TX 77030 USA;

  Univ Leipzig Dept Cardiol Leipzig Germany;

  Imperial Coll London Dept Primary Care &

  Publ Hlth London England;

  St Michaels Hosp Div Endocrinol &

  Metab Toronto ON Canada;

  Louisville Metab &

  Atherosclerosis Res Ctr Louisville KY USA;

  Washington Univ Sch Med Div Endocrinol Metab &

  Lipid Res St Louis MO USA;

  Acad Med Ctr Amsterdam Dept Vasc Med Netherlands Antilles Amsterdam Neth Antilles;

  Esper Therapeut Clin Dev Ann Arbor MI USA;

  Esper Therapeut Clin Dev Ann Arbor MI USA;

  Univ Milan Milan Italy;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 心脏、血管（循环系）疾病;
• 关键词